← Evidence map

ArticleNPJ systems biology and applications2022

CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy.

Marisol Salgado-Albarrán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35132075